Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Preliminary results Inv. presentation Quarterly results Director departure
|
Acutus Medical, Inc. (AFIB)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/07/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 433 shares
@ $0.69, valued at
$298.8 |
|
08/07/2023 |
4
| Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 134 shares
@ $0.69, valued at
$92.5 |
|
08/02/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 20,000 shares
@ $0 |
|
08/02/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 6,484 shares
@ $0 |
|
08/02/2023 |
4
| Mukai Takeo (CFO) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 501 shares
@ $0 |
|
06/29/2023 |
4/A
| ElBardissi Andrew (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 8,400 shares
@ $0 Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
06/15/2023 |
4
| Marzouk Shaden (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 8,400 shares
@ $0 Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
06/15/2023 |
4
| Sheridan John F (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 8,400 shares
@ $0 Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
06/15/2023 |
4
| Bonita David P (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 8,400 shares
@ $0 Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
06/15/2023 |
4
| Huennekens R Scott (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 10,920 shares
@ $0 Granted 25,480 options to buy
@ $0.8349, valued at
$21.3k
|
|
06/15/2023 |
4
| ElBardissi Andrew (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 8,400 shares
@ $0 Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
06/15/2023 |
4
| Garland Jason K (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 8,400 shares
@ $0 Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
06/15/2023 |
4
| Pellegrini Niamh Louise (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 8,400 shares
@ $0 Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
06/01/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 17,290 shares
@ $0.8479, valued at
$14.7k
|
|
04/04/2023 |
4
| Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 321 shares
@ $0.754, valued at
$242 |
|
04/04/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 3,165 shares
@ $0.754, valued at
$2.4k
|
|
04/04/2023 |
4
| Piscitello Charlie (SVP, Chief People Officer) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 855 shares
@ $0.754, valued at
$644.7 |
|
04/04/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 855 shares
@ $0.754, valued at
$644.7 |
|
03/02/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 42,500 shares
@ $0 Granted 42,500 options to buy
@ $1.41, valued at
$59.9k
|
|
03/02/2023 |
4
| Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 42,500 shares
@ $0 Granted 42,500 options to buy
@ $1.41, valued at
$59.9k
|
|
03/02/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 135,000 shares
@ $0 Granted 135,000 options to buy
@ $1.41, valued at
$190.4k
|
|
03/02/2023 |
4
| Mukai Takeo (CFO) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 47,500 shares
@ $0 Granted 47,500 options to buy
@ $1.41, valued at
$67k
|
|
03/02/2023 |
4
| Piscitello Charlie (SVP, Chief People Officer) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 42,500 shares
@ $0 Granted 42,500 options to buy
@ $1.41, valued at
$59.9k
|
|
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 10,196 shares
@ $1.87, valued at
$19.1k
|
|
02/02/2023 |
4
| Piscitello Charlie (SVP, Chief People Officer) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 6,627 shares
@ $1.87, valued at
$12.4k
|
|
02/02/2023 |
4
| Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 3,540 shares
@ $1.87, valued at
$6.6k
|
|
02/02/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Paid exercise price by delivering 6,525 shares
@ $1.87, valued at
$12.2k
|
|
10/11/2022 |
4
| Huennekens R Scott (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 2,520 shares
@ $0 Granted 5,880 options to buy
@ $0.88, valued at
$5.2k
|
|
09/02/2022 |
4
| Garland Jason K (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 14,000 shares
@ $0 Granted 32,500 options to buy
@ $1.13, valued at
$36.7k
|
|
09/02/2022 |
4
| Mukai Takeo (Interim CFO) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 20,000 shares
@ $0 |
|
08/29/2022 |
3
| Mukai Takeo (Interim CFO) has filed a Form 3 on Acutus Medical, Inc. |
08/29/2022 |
3
| Garland Jason K (Director) has filed a Form 3 on Acutus Medical, Inc. |
08/01/2022 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.
Txns:
| Granted 75,000 shares
@ $0 Disposed/sold 77,335 options to buy
@ $13.66, valued at
$1.1M
Granted 77,335 options to buy
@ $1.34, valued at
$103.6k
Disposed/sold 50,000 options to buy
@ $2.41, valued at
$120.5k
Granted 50,000 options to buy
@ $1.34, valued at
$67k
|
|
|
|
|